Pfizer Canada vaccine lead says lifting patents isn’t solution to inequity

The vaccine lead for Pfizer Canada says temporarily waiving intellectual property rights and patents isn’t the solution to COVID-19 vaccine inequity.

Post a Comment

0 Comments